Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: Insights from the Arterial Revascularization Trial by Benedetto, Umberto et al.
1 
Original Research Article 1 
 2 
Pedicled and skeletonized single and bilateral internal mammary artery grafts 3 
and the incidence of sternal wound complications: Insights from the Arterial 4 
Revascularization Trial (ART) 5 
 6 
Umberto Benedetto1 MD PhD, Douglas G Altman2 DSc, Stephen Gerry2 MSc, Alastair 7 
Gray3 PhD, Belinda Lees4 BSc PhD, Rafal Pawlaczyk5 PhD, Marcus Flather6 MD, 8 
David P Taggart4 MD PhD; on behalf of the ART investigators  9 
1Bristol Heart Institute, University of Bristol, School of Clinical Sciences, United 10 
Kingdom;  11 
2Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, 12 
Rheumatology & Musculoskeletal Sciences, University of Oxford, Oxford, UK;  13 
3Department of Public Health, Health Economics Research Centre, University of 14 
Oxford, Headington, Oxford, UK;  15 
4Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, 16 
Oxford, UK;  17 
5Department of Cardiovascular Surgery, Medical University of Gdansk, Poland;  18 
6Research and Development Unit, Norfolk and Norwich University Hospitals NHS 19 
Foundation Trust, Norwich, UK 20 
 21 
Clinical trial registration: ISRCTN46552265 22 
 23 
Disclosures: None 24 
 25 
Study support: ART is funded jointly by a grant from the British Heart Foundation 26 
(SP/03/001) and a grant from the Medical Research Council (G0200390).  27 
 28 
Word count:  29 
 30 
Corresponding Author 31 
Umberto Benedetto MD PhD 32 
Bristol Heart Institute, University of Bristol 33 
Level 7, Bristol Royal Infirmary,  34 
Upper Maudlin Street BS2 8HW 35 
Tel:+44 (0) 117 34 22856 36 
Email: Umberto.benedetto@bristol.ac.uk  37 
  38 
2 
Abbreviation 39 
ASMD: absolute standardised mean difference 40 
ART: Arterial Revascularization trial.   41 
ATE: average treatment effect on the population  42 
BIMA bilateral internal mammary artery 43 
CABG: coronary artery bypass grafting  44 
ESS: Effective sample size 45 
IMA: internal mammary artery 46 
SIMA: single internal mammary artery  47 
S: skeletonized  48 
P: pedicled  49 
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Structured Abstract 50 
Objective(s): The question of whether skeletonized internal mammary artery (IMA) 51 
harvesting reduces the incidence of sternal wound complications in comparison to the 52 
pedicled technique, in the context of single or bilateral IMAs, remains controversial. 53 
We studied the impact IMA harvesting strategy on sternal wound complication in the 54 
Arterial Revascularization trial (ART).  55 
Methods: Patients enrolled in the ART (n=3103) were randomised to coronary artery 56 
bypass grafting with single or bilateral IMAs. Sternal wound complication rates were 57 
examined according to the harvesting technique that was documented in 2056 58 
patients. The IMA harvesting technique, based on surgeon preference, resulted in 4 59 
groups: pedicled single IMA (P-SIMA, n=607), pedicled bilateral IMA (P-BIMA, n=459), 60 
skeletonized single IMA (S-SIMA, n=512) and skeletonized bilateral IMA (S-BIMA, 61 
n=478). Propensity Scores weighting was used to estimate the impact of the 62 
harvesting technique on sternal wound complications.  63 
Results: A total of 219 of 2056 patients (10.6%) experienced a sternal wound 64 
complication within 1 year from the index operation.  Of those, only 25 (1.2%) patients 65 
required sternal wound reconstruction. P-BIMA (OR 1.80; 95%CI 1.23 to 2.63) but not 66 
S-BIMA (OR 1.00; 95%CI 0.65 to 1.53) or S-SIMA (OR 0.89; 95%CI 0.57-1.38) was 67 
associated with a significantly increased risk of any sternal wound complications 68 
compared to P-SIMA.    69 
Conclusions: The present ART sub-study suggests that, with a skeletonization 70 
technique, the risk of sternal wound complication with BIMA grafting is at a 71 
similar level to that after standard pedicled SIMA harvesting whilst skeletonized 72 
SIMA harvesting did not add any further benefit when compared to pedicled 73 
SIMA harvesting.     74 
4 
Central picture: Incidence of sternal wound complications according to internal 75 
mammary artery harvesting strategies (P-SIMA: pedicled single internal mammary 76 
artery; P-BIMA: pedicled bilateral internal mammary arteries; S-SIMA: skeletonized 77 
SIMA; S-BIMA: skeletonized bilateral internal mammary arteries)  78 
5 
Central message  79 
In the Arterial Revascularization trial, the risk of sternal wound complication with 80 
bilateral internal mammary arteries was comparable to that after single pedicled 81 
harvesting.  82 
6 
Perspective Statement 83 
By using skeletonized harvesting technique, the risk of sternal wound complication 84 
with bilateral internal mammary artery (IMA) grafting is at a similar level to that after 85 
standard pedicled single IMA harvesting also in patients at higher risk such as insulin 86 
dependent diabetes, females and those with increased body mass index.   87 
Bilateral IMAs should not be denied on basis of increased risk of sternal wound 88 
complication if sketetonized harvesting technique is used.   89 
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The long term patency of conduits is one of the most important determinants of long-90 
term outcomes in coronary artery bypass grafting (CABG). The left internal mammary 91 
artery (IMA) is unanimously acknowledged as the best coronary conduit [1]. Although 92 
the right IMA has  identical function and patency rates to the left IMA and despite 93 
accumulation of evidence on long term benefit by using bilateral IMAs (BIMA) over the 94 
past 20 years [2-4], the right IMA remains largely underutilized [5] mainly due to 95 
concerns over the potential for sternal wound complications [6]. 96 
There are two established techniques for harvesting the IMA: pedicled and 97 
skeletonized. Harvesting the IMA(s) in a pedicled fashion can potentially lead to 98 
significant sternal devascularisation [7,8]. As opposed to pedicled harvesting, 99 
minimization of tissue mobilization during skeletonized IMA harvesting has been 100 
shown to preserve substantial collateral flow to the sternum by sparing some of the 101 
sternal and intercostal branches that arise from the internal mammary artery as a 102 
common trunk [7,8]. This finding may have potential clinical significance with respect 103 
to reducing the risk of sternal wound complications by improving wound healing and, 104 
in particular, when both left and right IMAs are used [9].  105 
However, the magnitude of the potential clinical benefit from skeletonized over 106 
pedicled IMA harvesting on sternal wound complications still remains to be determined 107 
[10,11]. Moreover, skeletonized IMA harvesting is a more technically demanding and 108 
time consuming technique and concerns remain over a perceived increased risk of 109 
injury to the IMAs during skeletonization that may affect early outcomes [12]. 110 
Consequently, in the absence of a general consensus, pedicled IMA harvesting, 111 
remains the generally preferred approach worldwide. 112 
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The Arterial Revascularization Trial (ART) is a randomized comparison of bilateral IMA 113 
(BIMA) versus single IMA (SIMA) grafting in CABG surgery [13] and is also one of the 114 
largest studies of contemporary CABG with a high proportion of patients undergoing 115 
skeletonized IMA harvesting. We studied the impact of IMA harvesting strategy on 116 
sternal wound complication by conducting an analysis of data collected prospectively 117 
in the Arterial Revascularization trial (ART).  118 
Methods 119 
This research adheres to the principles set forth in the Declaration of Helsinki 120 
(http://www.wma.net/en/30publications/10policies/b3/index.html). The ART has been 121 
approved by the institutional review board of all participating centers and informed 122 
consent was obtained from each participant. The protocol for ART has been published 123 
[14] Briefly, ART is a two-arm, randomized multicentre trial, conducted in 28 hospitals 124 
in seven countries, with patients being randomized equally to SIMA or BIMA grafts. 125 
Eligible patients were those with multivessel coronary artery disease (including urgent 126 
patients but not evolving myocardial infarction) undergoing CABG, whereas those 127 
requiring single grafts or redo CABG were excluded. Only surgeons with experience 128 
of ≥50 BIMA operations were able to participate in the trial; standard methods for 129 
anaesthesia and myocardial protection were used according to local practice. For the 130 
purpose of the present analysis, patients were classified according to the “as 131 
treated” principle in the following groups: pedicled single IMA (P-SIMA), 132 
skeletonized single IMA (S-SIMA), pedicled bilateral IMA (P-BIMA) and 133 
skeletonized BIMA (S-BIMA). IMA harvesting technique was based on surgeon 134 
preference. This information was not recorded from the outset of the trial. Thus only 135 
2056 out of 3102 patients were included in the analyses; among those 1022 and 136 
1034 were initially allocated to BIMA and SIMA respectively. Crossover rate from 137 
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BIMA to SIMA was 115/1022(11.2%) and from SIMA to BIMA was 30/1034(2.9%). 138 
Finally a total of 937 and 1119 patients received BIMA and SIMA respectively.  139 
Outcomes definition 140 
The primary end-point for these analyses was the incidence of any sternal wound 141 
complication within 1 year after the index procedure, which included a broad definition 142 
ranging from superficial sternal wound discharge to sternal wound reconstruction.  We 143 
also investigated the impact of IMA harvesting strategy on the incidence of severe 144 
sternal wound complications, defined as sternal wound infection requiring antibiotics 145 
and/or sternal wound reconstruction. Adverse events including sternal wound 146 
complications were adjudicated blind by a member of the Clinical Event Review 147 
Committee.   148 
Statistical analysis 149 
For baseline characteristics, variables are summarised as mean for continuous 150 
variables and percentage for categorical variables. The chi squared test was used to 151 
test unadjusted association between treatment variable and outcomes. Multiple 152 
imputation (m=3) was used to address missing data (165 patients). Rubin’s method 153 
[15] was used to combine results from each of m imputed data sets.   154 
Inverse probability of treatment weighting for modelling causal effects was 155 
used to for multiple treatments comparison [16]. One of the advantages of this 156 
technique over standard pairwise propensity matching is the possibility of 157 
simultaneous comparisons between multiple treatments. Moreover, all the 158 
individuals in the study can be used for the outcomes evaluation whilst a large 159 
number of subjects may not be used in a propensity matching in particular 160 
when the sample size of treatment and control groups are similar. A 161 
generalised boosted model was implemented to estimate multinomial propensity 162 
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scores (PS) adjusting for 14 pre-treatment covariates, and the propensity score was 163 
assumed as the probability that an individual with pre-treatment characteristics X 164 
receives treatment t (twang R package).The average treatment effect on the 165 
population (ATE) was used to answer the question of how, on average, the outcome 166 
of interest would change if everyone in the population of interest had been assigned 167 
to a particular treatment relative to if they had all received another single treatment. 168 
To estimate the ATE, we gave treated patients weight wi = 1/(1 – p(xi)), where p(xi) is 169 
the propensity score, and reference patients wi = 1/p(xi). P-SIMA was considered as 170 
the reference group in all comparisons. The absolute standardised mean difference 171 
(ASMD) was used as a balance metric to summarize the difference between two 172 
univariate distributions of a single pre-treatment variable. A value ≥0.20 (20%) was 173 
considered as an indicator of imbalance [17]. Effective sample size (ESS) was 174 
calculated to account for the potential loss in precision from weighting [16]. We then 175 
estimated the treatment effect estimates with a weighted regression model that 176 
contained only a treatment indicator. In addition, a combination of propensity score 177 
weighting and covariate adjustment (double robust) was used to correct the effect of 178 
IMA harvesting technique for residual imbalance and to estimate the effect size of 179 
other covariates. Lastly, we estimated the treatment effect within subgroups 180 
according to the presence of diabetes on insulin, gender and body mass index ≥30. 181 
R version 3.1.2 (2014-10-31) was used for all statistical analysis. 182 
Results 183 
Study population 184 
Among 2056 patients included in the present analysis, 1022 and 1034 were 185 
initially allocated to BIMA and SIMA respectively. Crossover rate from BIMA to 186 
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SIMA was 115/1022(11.2%) and from SIMA to BIMA was 30/1034(2.9%). Finally a 187 
total of 937 and 1119 patients received BIMA and SIMA respectively. IMA 188 
harvesting groups compared were:  607 P-SIMA, 459 P-BIMA, 512 S-SIMA and 189 
478 S-BIMA. The second IMA was initially attempted to be harvested but not 190 
used in 15 BIMA to SIMA crossovers. Of those, 5 were skeletonized and 10 were 191 
pedicled. Reasons for the second IMA not to be used were: evidence of injury 192 
during harvesting (n=4, all pedicled), unsatisfactory flow (n=5, 3 skeletonized, 2 193 
pedicled) or unsatisfactory length or size (n=6, 2 skeletonized, 4 pedicled). 194 
Overall, rate of injured/unsatisfactory second IMA was 5/483(1.0%) by using 195 
skeletonized technique and 10(2.1%) by using pedicled technique (P=0.22).  196 
Among those 15 cases, only 1 patient who received pedicled harvesting, 197 
experienced sternal wound complication. 198 
Distribution of pre-treatment variables among IMA harvesting technique groups 199 
Table 1 summarises the distribution of pre-treatment variables. Although the four 200 
groups were comparable for most of the pre-treatment variables, insulin dependent 201 
diabetes was more common in patients receiving S-BIMA than in patients receiving P-202 
BIMA. In addition more women received either skeletonized SIMA or BIMA. Finally off-203 
pump surgery was more frequently performed in S-SIMA and S-BIMA groups 204 
compared to pedicled groups.  205 
After multinomial propensity score estimation balance check showed that the groups 206 
were sufficiently similar (ASMDs <0.20) to support causal estimation of the treatment 207 
effects, although subjects receiving P-BIMA continued to have a slightly lower 208 
prevalence of diabetes on insulin.  209 
Incidence of sternal wound complications  210 
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A total of 219 out of 2056 patients (10.7%) experienced a sternal wound complication 211 
within 1 year from the index operation.  Of those, 75 (3.6%) patients had severe sternal 212 
wound complications including 50 (2.4%) with sternal wound infection requiring 213 
antibiotic therapy but not reconstruction and 25 (1.2%) who needed sternal wound 214 
reconstruction. Most sternal wound complications including those requiring 215 
reconstruction occurred during the first three months (Figure 1).  216 
Effect of harvesting technique on sternal wound complication 217 
Table 2 and Figure 2 show the incidence of any sternal wound complications according 218 
to IMA harvesting groups. P-BIMA patients had a higher incidence of any sternal 219 
wound complication compared to the other groups. There were too few severe wound 220 
complications to detect differences among the treatment groups. Table 3 summarises 221 
the effect of IMA harvesting technique on the incidence of any sternal wound 222 
complications. PS weighted analysis showed that P-BIMA but not S-BIMA was 223 
associated with a significantly increased risk (~ 2 times) of any sternal wound 224 
complications when compared to P-SIMA. On the other hand, S-SIMA did not provide 225 
any benefit on the incidence of any sternal wound complication when compared to P-226 
SIMA. When the analysis was restricted to severe sternal wound complications only 227 
we were unable to demonstrate any significant impact of P-BIMA (OR 1.60; 95%CI 228 
0.85-3.00), S-BIMA (OR 1.15;95%CI 0.58-2.28) and S-SIMA (OR 0.97; 95%CI 0.45-229 
2.07) when compared to P-SIMA.  230 
Subgroup analysis 231 
Subgroup analysis (Table 3) suggested that the detrimental effect of P-BIMA on the 232 
incidence of any sternal wound complication might be exaggerated in the presence of 233 
diabetes on insulin (OR 4.05; 95%CI 0.86-19.21) although this analysis was largely 234 
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underpowered due to the very small number of patients on insulin (n=118). Of note, 235 
P-BIMA remained significantly associated with a higher risk of any sternal wound 236 
complication in patients not diabetic (OR 1.84; 95%CI 1.18-2.85). Moreover P-BIMA 237 
significantly increased the risk of any sternal wound complication in both obese and 238 
non-obese patients.   239 
In the situation of a single IMA, skeletonized SIMA did not add any significant benefit 240 
in terms of sternal wound complication when compared to P-SIMA also among high 241 
risk subgroups.  242 
Independent risk factors for sternal wound complication  243 
In a double robust analysis (Table 4 and Table 5), P-BIMA but not S-BIMA remained 244 
independently associated with an increased risk of any sternal wound complication. 245 
Insulin dependent diabetes, female gender, and higher BMI were independent risk 246 
factors for any and severe sternal wound complications.    247 
Mortality within 30 days and at 1 year 248 
There were 31 (1.5%) deaths within 30 days and 55 (2.6%) deaths by 1 year follow-249 
up. Mortality at 30 day and 1 year was comparable among IMA harvesting groups 250 
(Table 2).  30 day mortality among patients with and without sternal wound 251 
reconstruction was 0/25(0%) and 31/2031(1.5%). At 1 year, total deaths among 252 
patients with and without sternal wound reconstruction were 3/25(12%) and 52/2031 253 
(2.7%).  254 
Discussion 255 
Despite increasing evidence from observational studies of the long term survival 256 
benefit of a second IMA [2,3], it remains largely underutilised being used in 4.1% of 257 
CABG in the USA [5], and around 10% in the UK and Australia [18]. Concern about 258 
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sternal wound complication is one of the main reasons limiting the use of more than 259 
one IMA, as a severe sternal wound complication dramatically increases in-hospital 260 
mortality as well as the expense of hospital stay [6].  261 
The present post hoc analysis of the ART demonstrates that in the modern era of 262 
CABG surgery sternal wound complications still affect about 10% of patients. In 263 
particular, severe sternal wound infection requiring antibiotic therapy or sternal wound 264 
reconstruction still affects nearly 2% and 1% of the surgical population respectively. 265 
The anticipated impact of sternal wound complication on resource consumption and 266 
patient outcomes represents an important consideration in the utilisation of BIMA 267 
grafting and an argument in favour of skeletonized IMA over pedicled IMA harvesting.   268 
The main finding of the present analysis is that BIMA harvesting can be safely 269 
performed using the skeletonized technique without increasing the risk of sternal 270 
wound complications when compared to the standard approach using a pedicled 271 
SIMA. Furthermore, skeletonized BIMA harvesting does not seem to significantly 272 
increase the risk even in higher risk groups, such as diabetics on insulin, females and 273 
the obese (BMI≥30). On the other hand, pedicled BIMA was associated with a nearly 274 
2 fold increased risk of any sternal wound complication. The detrimental effect of 275 
pedicled BIMA harvesting on sternal wound complication was relevant not only in high 276 
risk cases such as those who were obese or who had insulin dependent diabetes but 277 
also in the lowest risk CABG population who were not diabetic or obese, whilst 278 
skeletonized BIMA harvesting did not significantly increase the risk of sternal wound 279 
complications.  280 
15 
On the other hand, in the context of a single IMA graft, there was no evidence of the 281 
superiority of skeletonized SIMA harvesting over pedicled SIMA harvesting in reducing 282 
the risk of sternal wound complications.  283 
Skeletonized harvesting has been proposed to minimise the risk of sternal wound 284 
complication by preserving sternal perfusion especially in the context of BIMA usage 285 
[6]. Kamiya et al. [7] showed better oxygen saturation and blood flow in the 286 
microcirculation of sternal tissue when using skeletonized rather than pedicled IMA.  287 
Similarly, Boodhwani et al. [8], using radionuclear perfusion scanning, demonstrated 288 
that sternal perfusion was greater after skeletonized rather than pedicled harvesting. 289 
However, whether skeletonized IMA harvesting should be considered the standard 290 
approach with BIMA grafting and whether this approach also provides a significant 291 
benefit in SIMA grafting still needs to be determined. The potential clinical superiority 292 
of skeletonized over pedicled harvesting on sternal wound complications has been 293 
addressed only in a few studies with conflicting results reported [10-11]. Studies 294 
published to date are remarkably underpowered to detect any clinical benefit on low 295 
rate events such as sternal wound complications [11]. Moreover, skeletonized 296 
harvesting is more technically demanding and time consuming and, in the absence of 297 
general consensus, pedicled harvesting still remains the preferred approach 298 
worldwide.  299 
ART is one of the largest studies of contemporary CABG with a high proportion of 300 
patients undergoing skeletonized IMA harvesting [13]. To our knowledge, the present 301 
study is the largest analysis on the impact of IMA harvesting performed to date. We 302 
found that skeletonization while performing BIMA was safe as did not  increase 303 
the risk of damage to harvested IMA. In fact, rate of injured/unsatisfactory 304 
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second IMA was 1.0% by using skeletonized technique and 2.1% by using 305 
pedicled technique thus supporting previous reports [22]. Moreover, mortality 306 
rate at 30 days and 1 year was comparable among the two techniques. With 307 
regard to sternal wound complications, skeletonized BIMA harvesting did not 308 
increase its risk when compared to pedicled SIMA and subgroup analysis suggested 309 
a protective effect from skeletonized BIMA also among high risk subjects. On the other 310 
hand, pedicled BIMA grafts seemed to increase the risk of sternal wound 311 
complications also among low risk subgroups (ie not on insulin nor obese). We also 312 
found no evidence that skeletonized SIMA harvesting added any protective effect 313 
when compared to a pedicled SIMA.  314 
Limitations 315 
The present analysis has some limitations. Despite propensity score adjustment, the 316 
present analysis was unable to address hidden biases due to unobserved differences 317 
between treated and control patients before treatment.  The present study was 318 
underpowered to detect differences in severe sternal wound complications among 319 
groups and most of sternal complications were clinically less relevant. 320 
Fortunately, the low incidence of severe sternal wound complications would have 321 
required a much larger number of patients for analysis. Nevertheless, the difference 322 
in the rate of severe wound problems between the 2 groups supports the intrinsic 323 
benefit of the skeletonized technique of artery harvesting in terms of severe sternal 324 
wound complications. Sparing of the communicating bifurcation of internal 325 
mammary artery to the chest wall and preservation of pericardiacophrenic artery 326 
branch has been reported to minimize the risk of sternal wound complication in 327 
patients receiving pedicled BIMA [23]. In the present study we could not confirm 328 
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this hypothesis as data on technical aspects of harvesting technique were not 329 
reported.  330 
Conclusion  331 
In conclusion, the present ART sub-study suggests that, with a skeletonization 332 
technique, the risk of sternal wound complication with BIMA grafting is at a similar level 333 
to that after standard pedicled SIMA harvesting whilst skeletonized SIMA harvesting 334 
did not add any further benefit when compared to pedicled SIMA harvesting. 335 
Skeletonized BIMA harvesting seems to provide a protective effect also in those at 336 
higher risk such as insulin dependent diabetes, females and those with increased BMI.   337 
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Table 1. Distribution of pre-treatment variables (as mean or percentage)  before (unweighted) and after (weighted) propensity score  
ASMD: absolute standardised mean difference; SD= standard deviation for all patients; P-SIMA: pedicled single internal mammary artery; P-BIMA: 
pedicled bilateral internal mammary arteries; S-SIMA: skeletonized SIMA; S-BIMA: skeletonized bilateral internal mammary arteries; ESS: effective 
sample size; BMI: body mass index; NYHA: New York Heart Association; COPD: chronic obstructive pulmonary disease; PVD: peripheral vascular 
disease; MI: myocardial infarction; LVEF: left ventricular ejection fraction  
 P-SIMA 
n=607 
S-SIMA 
n=512 
P-BIMA 
n=459 
S-BIMA 
n=478 
ASMD P P-SIMA 
ESS=550 
S-SIMA 
ESS =454 
P-BIMA 
ESS =429 
S-BIMA 
ESS =430 
ASMD P 
 Unweighted 
 
 Weighted 
 
 
Age, year (SD=9) 64 65 63 64 
0.23 <0.001 
64 64 64 64 
0.06 0.36 
Female  11% 19% 12% 14% 
0.22 <0.001 
12% 14% 13% 12% 
0.05 0.36 
BMI (SD=4) 28.29 28.17 28.30 28.38 
0.05 0.44 
28.24 28.28 28.31 28.24 
0.02 0.77 
Creatinine,mmol/l (SD=22) 97.91 100.00 98.23 98.30 
0.09 0.13 
97.83 98.97 98.36 98.43 
0.05 0.37 
NYHA III/IV  26% 19% 28% 22% 
0.20 <0.001 
24% 22% 24% 21% 
0.06 0.37 
Diabetes orally treated  19% 19% 19% 19% 
0.02 0.70 
18% 19% 19% 19% 
0.02 0.73 
Diabetes on insulin  5% 6% 3% 8% 
0.21 <0.001 
5% 6% 3% 6% 
0.13 0.02 
Smoker  12% 13% 14% 16% 
0.10 0.10 
13% 13% 13% 14% 
0.03 0.65 
COPD  7% 6% 9% 6% 
0.13 0.05 
7% 7% 7% 6% 
0.04 0.51 
PVD  9% 8% 7% 7% 
0.07 0.27 
7% 8% 7% 8% 
0.04 0.61 
Prior stroke   3% 4% 2% 3% 0.09 
0.16 
3% 3% 2% 3% 
0.09 0.10 
Prior MI  42% 44% 39% 35% 
0.19 <0.001 
41% 41% 42% 39% 
0.06 0.38 
LVEF <.50  28% 26% 23% 21% 
0.16 0.01 
26% 25% 25% 23% 
0.06 0.39 
Caucasian  91% 92% 88% 92% 
0.15 0.02 
91% 92% 91% 93% 
0.07 0.28 
On pump  56% 42% 52% 39% 
0.35 0.00 
49% 46% 48% 46% 
0.07 0.29 
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Table 2. Outcomes among treatment groups.  
 
 All SWC 
(n=219) 
Severe SWC 
(n=150) 
30 day 
mortality 
(n= 31) 
1 year 
mortality 
(n=55) 
  All  
(n=75) 
SWC requiring 
antibiotics 
(n=50) 
Sternal wound 
reconstruction 
(n=25) 
  
P-SIMA (n=607) 58 (9.5%) 20 (3.3 %) 14(2.3%) 6 (1.0%) 8 (1.3%) 13 (2.1%) 
S-SIMA (n=512) 41(8.0%) 14 (2.7 %) 12(2.3%) 2(0.4%) 8 (1.6%) 15 (2.9%) 
P-BIMA (n=459) 74 (16.1%) 24 (5.2 %) 17(3.7%) 7(1.5%) 7 (1.5%) 12 (2.6%) 
S-BIMA (n=478) 46(9.6%) 17 (3.7 %) 7(1.5%) 10(2.1%) 8 (1.7%) 15 (3.1%) 
       
2 tests P 
P-SIMA as reference 
      
S-SIMA 0.39 0.60 1 0.30 0.80 0.44 
P-BIMA 0.0014 0.12 0.19 0.57 0.79 0.68 
S-BIMA 1 0.86 0.37 0.20 0.62 0.33 
P-SIMA: pedicled single internal mammary artery; P-BIMA: pedicled bilateral internal mammary arteries; S-SIMA: skeletonized 
SIMA; S-BIMA: skeletonized bilateral internal mammary arteries; SWC: sternal wound complication 
24 
Table 3. Propensity Score weighted effect (OR[95%CI]) of internal mammary artery harvesting on sternal wound complication.   
Bold: P<0.05; OR: Odds ratio; CI: confidence interval; P-SIMA: pedicled single internal mammary artery; P-BIMA: pedicled bilateral 
internal mammary arteries; S-SIMA: skeletonized SIMA; S-BIMA: skeletonized bilateral internal mammary arteries; BMI: Body Mass 
index 
 
 
  
 Overall 
 
 
Diabetes 
On insulin 
 
Diabetes 
Orally treated 
 
Not Diabetic 
 
 
Female 
 
 
Male 
 
 
BMI≥30 
 
BMI<30 
 
Comparison 
P-SIMA as ref 
N=2056 N=118 N=386 N=1552 N=283 N=1773 N=631 N=1425 
P-BIMA  
 
1.80            
[1.23-
2.63] 
4.05                 
[0.86-19.21] 
1.41 
[0.58-3.45] 
1.84              
[1.18-2.85] 
1.08           
[0.41-2.83] 
1.96            
[1.30-2.98] 
2.07        
[1.09-3.90] 
1.67           
[1.03-2.68] 
S-SIMA   
 
0.89              
[0.57-1.38] 
1.35                   
[0.29-6.15] 
1.25                  
[0.49-3.19] 
0.75               
[0.43-1.29] 
0.72             
[0.27-1.90] 
0.91            
[0.55-1.51] 
1.46          
[0.73-2.90] 
1.09           
[0.65-1.83] 
S-BIMA  
 
1.00             
[0.65-1.53] 
1.92                        
[0.48-7.73] 
1.54                  
[0.64-3.73] 
0.78                  
[0.46-1.34] 
1.59              
[0.65-3.91] 
0.86           
[0.52-1.42] 
0.83           
[0.39-1.80] 
0.59             
[0.32-1.09] 
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Table 4. Results of double robust Propensity Score-weighted analysis on the incidence 
of any sternal wound complication  
 OR 95%CILL 95%CI UL P 
P-BIMA vs P-SIMA 1.85 1.25 2.74 0.002 
S-SIMA vs P-SIMA 0.98 0.64 1.52 0.94 
S-BIMA vs P-SIMA 0.87 0.55 1.36 0.53 
Age† 1.00 0.99 1.02 0.77 
Female 1.58 1.07 2.34 0.02 
BMI† 1.08 1.04 1.13 <0.001 
Creatinine† 0.99 0.98 1.00 0.01 
NYHA III-IV 1.01 0.70 1.45 0.96 
Diabetes orally treated 1.20 0.82 1.74 0.34 
Diabetes on insulin 2.17 1.29 3.66 0.003 
Smoking 1.27 0.83 1.95 0.27 
COPD 1.23 0.70 2.18 0.47 
PVD 0.81 0.44 1.48 0.49 
Prior stroke 1.67 0.80 3.50 0.17 
Prior MI 0.94 0.68 1.30 0.70 
LVEF<.50 1.02 0.71 1.46 0.91 
Caucasian 1.09 0.79 1.50 0.59 
† used as continuous variable; Odds ratio; LLCI: confidence interval lower limit; CI UL: 
confidence interval upper limit 
P-SIMA: pedicled single internal mammary artery; P-BIMA: pedicled bilateral internal 
mammary arteries; S-SIMA: skeletonized SIMA; S-BIMA: skeletonized bilateral 
internal mammary arteries; BMI: body mass index; NYHA: New York Heart 
Association; COPD: chronic obstructive pulmonary disease; PVD: peripheral vascular 
disease; MI: myocardial infarction; LVEF: left ventricular ejection fraction  
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Table 5. Results of double robust Propensity Score-weighted analysis on the 
incidence of severe sternal wound complication  
 OR 95%CI LL 95%CI UL P 
P-BIMA vs P-SIMA 1.61 0.85 3.07 0.15 
S-SIMA vs P-SIMA 1.14 0.56 2.31 0.71 
S-BIMA vs P-SIMA 0.92 0.43 1.98 0.82 
Age† 1.00 0.97 1.03 0.79 
Female 2.48 1.38 4.45 0.002 
BMI† 1.11 1.04 1.18 0.001 
Creatinine† 1.00 0.99 1.01 0.76 
NYHA III-IV 0.83 0.42 1.61 0.57 
Diabetes orally treated 1.78 1.00 3.16 0.049 
Diabetes on insulin 2.72 1.25 5.92 0.01 
Smoking 1.72 0.88 3.35 0.11 
COPD 2.08 0.97 4.46 0.06 
PVD 0.53 0.17 1.66 0.27 
Prior stroke 1.74 0.62 4.90 0.29 
Prior MI 0.92 0.54 1.59 0.77 
LVEF<.50 1.03 0.56 1.87 0.93 
Caucasian 1.26 0.73 2.18 0.40 
† used as continuous variable; Odds ratio; LLCI: confidence interval lower limit; CI UL: 
confidence interval upper limit 
P-SIMA: pedicled single internal mammary artery; P-BIMA: pedicled bilateral internal 
mammary arteries; S-SIMA: skeletonized SIMA; S-BIMA: skeletonized bilateral 
internal mammary arteries; BMI: body mass index; NYHA: New York Heart 
Association; COPD: chronic obstructive pulmonary disease; PVD: peripheral vascular 
disease; MI: myocardial infarction; LVEF: left ventricular ejection fraction  
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Figure Legends 
Figure 1. Time from index operation to any and severe sternal wound complication  
Figure 2. Incidence of any sternal wound complication according to internal 
mammary artery harvesting strategies. (P-SIMA: pedicled single internal mammary 
artery; P-BIMA: pedicled bilateral internal mammary arteries; S-SIMA: skeletonized 
SIMA; S-BIMA: skeletonized bilateral internal mammary arteries) 
